Experienced in Glucose-6-Phosphate Dehydrogenase Deficiency

Michael J. Sgro

Toronto, ON, CA 
Experienced in Glucose-6-Phosphate Dehydrogenase Deficiency
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Michael Sgro practices in Toronto, Canada. Mr. Sgro is rated as an Experienced expert by MediFind in the treatment of Glucose-6-Phosphate Dehydrogenase Deficiency. His top areas of expertise are Transient Familial Hyperbilirubinemia, Newborn Jaundice, Neonatal Sepsis, and Hemolytic Disease of the Newborn.

His clinical research consists of co-authoring 54 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Glucose-6-Phosphate Dehydrogenase Deficiency.

Gender
Male

Locations

Toronto, ON, Canada
Other Locations
7141 Sherbrooke St. W, Montreal, QC H4B1R6, Canada
Toronto, Canada
2500 University Drive N.W., Calgary, AB T2N1N4, Canada
80 St. George St. Toronto, St. George, ON M5S3H6, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Efficacy Study of the Draeger Jaundice Meter (JM-105) in Providing TcB Measurements to Estimate TSB in Neonates of ≥ 24 Weeks of Gestational Age Who Have and Have Not Undergone Phototherapy
Efficacy Study of the Draeger Jaundice Meter (JM-105) in Providing TcB Measurements to Estimate TSB in Neonates of ≥ 24 Weeks of Gestational Age Who Have and Have Not Undergone Phototherapy
Enrollment Status: Completed
Publish Date: February 07, 2019
Intervention Type: Device
Study Phase: Not Applicable

54 Total Publications

Severe neonatal hyperbilirubinemia in infants aged 60 days or less (2025 to 2027).
Severe neonatal hyperbilirubinemia in infants aged 60 days or less (2025 to 2027).
Journal: Paediatrics & child health
Published: June 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Sgro's expertise for a condition
ConditionClose
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile